Mass Medical Angels
Brookline, Massachusettsmassmedangels.com
Overview
Mass Medical Angels (MA2) is a seed stage investor group exclusively focused on life science and healthcare investments. Our mission is to bring more clinical tools to the marketplace while attaining superior returns for our investors. To do this, we provide financing and mentoring to early-stage life-science companies so that they can obtain further funding, reach positive cash-flows, or get acquired. We invest in medical devices, therapeutics, diagnostics, health services, health information technologies, and relevant research-related tools including laboratory equipment.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Entirety Biomedical | Feb 2026 | Seed | Co-investor |
| Cayuga Biotech | Dec 2025 | Seed | Co-investor |
| iQure Pharma | Nov 2023 | Series A | Lead |
| Astrocyte Pharmaceuticals Inc. | Aug 2023 | VC Round | Co-investor |
| Astrocyte Pharmaceuticals Inc. | May 2021 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.